We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin.
- Authors
Chevallier, P.; Prebet, T.; Pigneux, A.; Hunault, M.; Delaunay, J.; Perry, F.; Lode, L.; Richebourg, S.; Blanchet, O.; Vey, N.; Ifrah, N.; Milpied, N.; Blaise, D.; Harousseau, J.-L.; Mohty, M.
- Abstract
A letter to the editor in response to the article "Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin," published in a previous issue is presented.
- Subjects
LETTERS to the editor; ACUTE myeloid leukemia; PATIENTS; AMINOGLYCOSIDES; ANTINEOPLASTIC agents; THERAPEUTIC use of monoclonal antibodies; CANCER relapse; GENOMES; KARYOTYPES; MONOCLONAL antibodies; GENETIC mutation; PROGNOSIS; TRANSFERASES; TREATMENT effectiveness; NUCLEAR proteins; SALVAGE therapy; THERAPEUTICS
- Publication
Leukemia (08876924), 2010, Vol 24, Issue 2, p467
- ISSN
0887-6924
- Publication type
letter
- DOI
10.1038/leu.2009.214